Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Nyctalopin anticorps (N-Term)

Cet anticorps anti-Nyctalopin est un anticorps Lapin Polyclonal détectant Nyctalopin dans WB. Adapté pour Humain.
N° du produit ABIN653436

Aperçu rapide pour Nyctalopin anticorps (N-Term) (ABIN653436)

Antigène

Voir toutes Nyctalopin (NYX) Anticorps
Nyctalopin (NYX)

Reactivité

  • 11
  • 1
Humain

Hôte

  • 11
Lapin

Clonalité

  • 11
Polyclonal

Conjugué

  • 6
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Nyctalopin est non-conjugé

Application

  • 11
  • 9
  • 2
  • 1
Western Blotting (WB)

Clone

RB23621
  • Épitope

    • 7
    • 2
    • 2
    • 2
    AA 53-80, N-Term

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This NYX antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 53-80 amino acids from the N-terminal region of human NYX.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

    Date de péremption

    6 months
  • Antigène

    Nyctalopin (NYX)

    Autre désignation

    NYX

    Sujet

    The product of this gene belongs to the small leucine-rich proteoglycan (SLRP) family of proteins. Defects in this gene are the cause of congenital stationary night blindness type 1 (CSNB1), also called X-linked congenital stationary night blindness (XLCSNB). CSNB1 is a rare inherited retinal disorder characterized by impaired scotopic vision, myopia, hyperopia, nystagmus and reduced visual acuity. The role of other SLRP proteins suggests that mutations in this gene disrupt developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB. [provided by RefSeq].

    Poids moléculaire

    52000

    ID gène

    60506

    NCBI Accession

    NP_072089

    UniProt

    Q9GZU5
Vous êtes ici:
Chat with us!